The Epidemiology and Prevalence of Barrett's Esophagus

Barrett's Esophagus and Esophageal Adenocarcinoma: Second Edition

Volumn , Issue , 2007, Pages 8-18

  Cameron, Alan J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Barrett's esophagus; Endoscopy; Epidemiology; Geographic differences; Reflux symptoms

Indexed keywords

EID: 7044226097     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470987513.ch2     Document Type: Chapter

References (73)

1. Barrett NR. Chronic peptic ulcer of the oesophagus and 'oesophagitis'. Brit J Surg 1950;38:175-82.
2. Allison PR, Johnstone AS. Oesophagus lined with gastric mucous membrane. Thorax 1953;8:87-101.
3. Sampliner RE and The Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Amer J Gastroenterol 2002;97:1888-95.
4. Spechler SJ, Zeroogian JM, Antonioli DA et al. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1994;344:1533-6.
5. Morales TG, Sampliner RE, Bhattacharyya A. Intestinal metaplasia of the gastric cardia. Amer J Gastroenterol 1997;92:414-8.
6. Weinstein WM, Leh W, Lewin K et al. How often is short segment Barrett's esophagus proven histologically? A prospective study. Gastroenterology 2002;122(suppl 1):A293.
7. Sharma S, Morales TG, Sampliner S. Short segment Barrett's esophagus-the need for standardization of the definition and of endoscopic criteria. Amer J Gastroenterol 1998;93:1033-6.
8. Burgess JN, Payne WS, Andersen HA, Weiland LH, Carlson HC. Barrett esophagus. The columnarepithelial lined esophagus. Mayo Clin Proc 1971;46:728-34.
9. Naef AP, Savary M. Conservative operations for peptic esophagitis with stenosis in columnar-lined lower esophagus. Ann Thoracic Surg 1972;13:543-51.
10. Burbidge E, Radigan JJ. Characteristics of the columnar-lined (Barrett's) esophagus. Gastroint Endosc 1979;25:133-6.
11. Cooper BT, Barbezat GO. Barrett's esophagus: a clinical study of 52 patients. Quart J Med 1987;62:97-108.
12. Gruppo Operativo per lo studio delle precancerosi dell esophago (GOSPE). Barrett's esophagus:epidemiological and clinical results of a multicentric survey. Int J Cancer 1991;48:364-8.
13. Cameron AJ, Lomboy CT. Barrett's esophagus: age, prevalence and the extent of columnar epithelium. Gastroenterology 1992;103:1241-5.
14. Hirota WK, Loughney TM, Lazas DJ et al. Specialized intestinal metaplasia, dysplasia and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999;116:277-85.
15. Caygill CPJ, Reed PI, Johnston BJ et al. A single center's 20-year experience of columnar-lined (Barrett's) oesophagus diagnosis. Eur J Gastroenterol Hepatol 1999;11:1355-8.
16. Todd JA, Johnston DA, Dillon JF. The changing spectrum of gastroesophageal reflux disease. Eur J Cancer Prev 2002;11:215-9.
17. Ford AC, Reynolds PD, Forman D, Cooper B, Moayyedi P. A retrospective case control study to determine the risk of Barrett's esophagus according to ethnic origin. Gut 2004;53(suppl 1):A26.
18. Philips RW, Wong RKH. Barrett's esophagus: natural history, incidence, etiology, and complications. Gastroenterol Clin N Amer 1991;20:791-816.
19. Winters C, Spurling TJ, Chobanian SJ et al. Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 1987;92:118-24.
20. Mann NS, Tsai MF, Nair PK. Barrett's esophagus in patients with symptomatic reflux esophagitis. Am J Gastroenterol 1989;84:1494-6.
21. Cameron AJ, Kamath PS, Carpenter HA. Prevalence of Barrett's esophagus and intestinal metaplasia at the esophagogastric junction. Gastroenterology 1997; 112:A82.
22. Romero Y, Cameron AJ, McDonnell SK et al. Family history doubles Barrett's esophagus risk. Gastroenterology 2002;122(suppl 1):A292.
23. Romero Y, Cameron AJ, Schaid DJ et al. Barrett's esophagus: prevalence in symptomatic relatives. Am J Gastroenterol 2002;97:1127-32.
24. Cameron AJ, Epidemiologic studies and the development of Barrett's esophagus. Endoscopy 1993;25(9):635-6.
25. El-Serag HB, Bailey NR, Gilger M, Rabeneck L. Endoscopic manifestations of gastroesophageal reflux disease in patients between 18 months and 25 years without neurological deficits. Amer J Gastroenterol 2002;97:1635-9.
26. Hassall E. Barrett's esophagus: congenital or acquired? Amer J Gastroenterol 1993;88:819-24.
27. Caygill CPJ, Watson A, Reed PI, Hill MJ. Characteristics and regional variations of patients with Barrett's esophagus in the UK. Eur J Gastroent Hep 2003;15:1217-22.
28. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF, Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-9.
29. Lieberman DA, Oehlke M, Helfand M, and the GORGE consortium. Risk factors for Barrett's esophagus in community-based practice. Amer J Gastroenterol 1997;92:1293-7.
30. Williamson WA, Ellis FH, Gibb SP et al. Barrett's esophagus. Prevalence and incidence of adenocarcinoma. Arch Int Med 1991;151:2212-6.
31. Van Sandick JW, Van Lanschot JJB, Kuiken BW et al. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on patholological stage and clinical outcome of Barrett's carcinoma. Gut 1998;43:216-22.
32. Menke-Pluymers MBE, Schoute NW, Mulder AH et al. Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus. Gut 1992;33:1454-8.
33. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002;123:461-7.
34. Rex DK, Cummings OW, Shaw S et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 2003;125:1670-7.
35. Nasseri-Moghaddam S, Malekzadeh R, Sotoudeh M et al. Lower esophagus in dyspeptic Iranian patients:a prospective study. J Gastroentero Hepatol 2003;18:315-21.
36. Toruner M, Soykan I, Enzari A et al. Barrett's esophagus:prevalence and its relationship with dyspeptic symptoms. J Gastroentero Hepatol 2004;19:535-40.
37. Rajendra S, Kutty K, Karim N. Ethnic differences in the prevalence of endoscopic esophagitis and Barrett's esophagus: the long and the short of it. Dig Dis Sci 2004;39:237-42.
38. Lee JI, Park H, Jung HW et al. Prevalence of Barrett's esophagus in an urban Korean population. J Gastroenterol 2003;38:23-7.
39. Azuma N, Endo T, Arimura Y et al. Prevalence of Barrett's esophagus and expression of mucin antigens detected by a panel of monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma in Japan. J Gastroenterol 2000;35:583-92.
40. Wong WM, Lam SK, Hui WM et al. Long-term prospective follow-up of endoscopic oesophagitis in southern Chinese-prevalence and spectrum of the disease. Aliment Pharmacol Ther 2002;16:2037-42.
41. Mason RJ, Bremner CG. The columnar-lined (Barrett's) oesophagus in black patients. S Afr J Surg 1998;36:61-2.
42. Kang JY. Systematic review: geographical and ethnic differences in gastro-esophageal reflux disease. Aliment Pharmacol Ther 2004;20:705-17.
43. Hongo M, Shoji T. Epidemiology of reflux disease and CLE in East Asia. J Gastroenterol 2003;38(suppl XV):25-30
44. Nebel OT, Fornes MF, Castell DO. Symptomatic gastresophageal reflux: incidence and precipitating factors. Dig Dis Sci 1976;21:953-6.
45. Locke GR, III, Talley NJ, Fett SR, Zinsmeister AR, Melton LJ, III. Prevalence and clinical spectrum of gastroesophageal reflux: a population based study in Olmsted County, Minnesota. Gastroenterology 1997; 112:1448-56.
46. Thompson WG, Heaton KW. Heartburn and globus in apparently healthy people. Canad Med Ass J 1982;126:46-8.
47. Isolauri J, Laippala P. Prevalence of symptoms suggestive of gastroesophageal reflux in an adult population. Ann Med 1995;27:67-70.
48. Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 1990;99:918-22.
49. Ormsby AH, Kilgore SP, Goldblum JR et al. The location and frequency of intestinal metaplasia at the esophagogastric junction in 223 consecutive autopsies: implications for patient treatment and preventive strategies in Barrett's esophagus. Mod Pathol 2000;13:614-20.
50. Cameron AJ, Lomboy CT, Pera M, Carpenter HA. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995;109:1541-6.
51. Hamilton SR, Smith RRL, Cameron JL. Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol 1988;19:942-8.
52. Theisen J, Stein HJ, Dittler HJ et al. Preoperative chemotherapy unmasks underlying Barrett's mucosa in patients with adenocarcinoma of the distal esophagus. Surg Endosc 2002;16:671-3.
53. Corley DA, Levin TR, Habel LA et al. Surveillance and survival in Barrett's adenocarcinomas: a populationbased study. Gastroenterology 2002;122:633-40.
54. Dulai GS, Guha S, Kahn KL, Gornbein J, Weinstein WM. Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review. Gastroenterology 2002;122:26-33.
55. Conio M, Cameron AJ, Romero Y et al. Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota. Gut 2001;48:304-9.
56. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510-3.
57. Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-53.
58. Crabb DW, Berk MA, Hall TR et al. Familial gastroesophageal reflux and development of Barrett's esophagus. Ann Int Med 1985;103:52-4.
59. Jochem VJ, Fuerst PA, Fromkes JJ. Familial Barrett's esophagus associated with adenocarcinoma. Gastroenterology 1992;102:1400-2.
60. Fahmy N, King JF. Barrett's esophagus: an acquired condition with genetic predisposition. Am J Gastroenterol 1993;88:1262-5.
61. Cameron AJ, Lagergren J, Henriksson C et al. Gastroesophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology 2002;122:55-9.
62. Mohammed I, Cherkas LF, Riley SA, Spector TD, Trudgill NJ. Genetic influences in gastro-oesophageal reflux disease: a twin study. Gut 2003;52:1085-9.
63. Romero Y, Cameron AJ, Locke GR, III et al. Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology 1997;113:1449-56.
64. Trudgill NJ, Kapur KC, Riley AS. Familial clustering of reflux symptoms. Am J Gastroenterol 1999;94:1172-8.
65. Romero Y, Cameron AJ, Schaid DJ et al. Barrett's esophagus: prevalence in symptomatic relatives. Am J Gastroenterol 2002;97:1127-32.
66. Romero Y, Cameron AJ, McDonnell S et al. Family history doubles Barrett's esophagus risk. Gastroenterology 2002;122(suppl 1):A292.
67. Caygill CPJ, Johnston DA, Lopez M et al. Lifestyle factors and Barrett's esophagus. Amer J Gastroenterol 2002;97:1328-31.
68. Conio M, Filiberti R, Blanchi S et al. Risk factors for Barrett's esophagus: a case-control study. Int J Cancer 2002;97:226-9.
69. Schnell TG, Sontag SJ, Chejfec G. Adenocarcinomas arising in tongues or short segments of Barrett's esophagus. Dig Dis Sci 1992;37:137-43.
70. Johnston MH, Hammond AS, Laskin W, Jones DM. The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy. Amer J Gastroenterol 1996;91:1507-11.
71. Weston AP, Krmpotich P, Makdisi WF et al. Short segment Barrett's esophagus: clinical and histological features, associated endoscopic findings, and association with gastric intestinal metaplasia. Amer J Gastroenterol 1996;91:981-6.
72. Voutilanen M, Farkkila M, Juhola M et al. Specialized columnar epithelium of the esophagogastric junction:prevalence and associations. Am J Gastroenterol 1999;94:913-8.
73. Nandurkar S, Talley NJ. Barrett's esophagus: the long and short of it. Amer J Gastroenterol 1999;94:30-40.